Literature DB >> 14724448

Retransplantation in patients with graft loss caused by polyoma virus nephropathy.

Emilio Ramos1, Flavio Vincenti, Wei X Lu, Ron Shapiro, Jennifer Trofe, Robert J Stratta, Johann Jonsson, Parmjeet S Randhawa, Cinthia B Drachenberg, John C Papadimitriou, Matthew R Weir, Ravinder K Wali.   

Abstract

The characteristics and outcome in 10 patients who underwent retransplantation after losing their renal grafts to BK virus-associated nephropathy (BKAN) are described. The patients underwent retransplantation at a mean of 13.3 months after failure of the first graft. Nephroureterectomy of the first graft was performed in seven patients. Maintenance immunosuppression regimens after the first and second grafts were similar, consisting of a combination of a calcineurin inhibitor, mycophenolate mofetil, and prednisone. BKAN recurred in one patient 8 months after retransplantation, but stabilization of graft function was achieved with a decrease in immunosuppression and treatment with low-dose cidofovir. After a mean follow-up of 34.6 months, all patients were found to have good graft function with a mean creatinine of 1.5 mg/dL. From this collective experience from five transplant centers (although the follow-up after retransplantation was not extensive), it can be concluded that patients with graft loss caused by BKAN can safely undergo retransplantation. The risk of recurrence does not seem to be increased in comparison with the first graft.

Entities:  

Mesh:

Year:  2004        PMID: 14724448     DOI: 10.1097/01.TP.0000095898.40458.68

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

1.  Viral epidemiologic shift in inflammatory heart disease: the increasing involvement of parvovirus B19 in the myocardium of pediatric cardiac transplant patients.

Authors:  John P Breinholt; Mousumi Moulik; William J Dreyer; Susan W Denfield; Jeffrey J Kim; John L Jefferies; Joseph W Rossano; Corey M Gates; Sarah K Clunie; Karla R Bowles; Debra L Kearney; Neil E Bowles; Jeffrey A Towbin
Journal:  J Heart Lung Transplant       Date:  2010-04-24       Impact factor: 10.247

Review 2.  Canadian Society of Transplantation: consensus guidelines on eligibility for kidney transplantation.

Authors:  Greg Knoll; Sandra Cockfield; Tom Blydt-Hansen; Dana Baran; Bryce Kiberd; David Landsberg; David Rush; Edward Cole
Journal:  CMAJ       Date:  2005-11-08       Impact factor: 8.262

3.  Kidney retransplantation for BK virus nephropathy with active viremia without allograft nephrectomy.

Authors:  Jingbo Huang; Gabriel Danovitch; Phuong-Thu Pham; Suphamai Bunnapradist; Edmund Huang
Journal:  J Nephrol       Date:  2015-04-25       Impact factor: 3.902

Review 4.  BK virus nephritis after renal transplantation.

Authors:  Aaron Dall; Sundaram Hariharan
Journal:  Clin J Am Soc Nephrol       Date:  2008-03       Impact factor: 8.237

Review 5.  Advances in BK Virus Complications in Organ Transplantation and Beyond.

Authors:  Abraham Cohen-Bucay; Silvia E Ramirez-Andrade; Craig E Gordon; Jean M Francis; Vipul C Chitalia
Journal:  Kidney Med       Date:  2020-10-11

6.  Role of Renal Re-transplantation in ESRD Patients.

Authors:  Alireza Ghadian; Mohammad Hossein Nourbala
Journal:  Nephrourol Mon       Date:  2013-03-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.